muramylnac-ala-isogln-lys-tripeptide has been researched along with Cancer of Skin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Favaro, D; Freschi, A; Galligioni, E; Quaia, M; Santarosa, M; Spada, A; Talmini, R | 1 |
| Fidler, IJ; Guo, S; Klabansky, R; Lenz, BF; Oldham, RK; Riggs, C; Simon, R; Talmadge, JE | 1 |
2 other study(ies) available for muramylnac-ala-isogln-lys-tripeptide and Cancer of Skin
| Article | Year |
|---|---|
Soluble intercellular adhesion molecule-1 in melanoma patients treated with liposomes containing muramyl tripeptide.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Cytokines; Humans; Intercellular Adhesion Molecule-1; Liposomes; Melanoma; Skin Neoplasms | 1995 |
Therapy of autochthonous skin cancers in mice with intravenously injected liposomes containing muramyltripeptide.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Female; Immunotherapy; Liposomes; Macrophages; Mice; Neoplasms, Radiation-Induced; Phosphatidylethanolamines; Skin Neoplasms | 1986 |